Martin Shkreli Says on Twitter He May Testify on Drug Prices

  • Former Turing CEO took the Fifth last time he visited Congress
  • Executive says he has ‘lots of insight’ into price controversy

Martin Shkreli.

Photographer: John Taggart/Bloomberg

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, may appear before Congress to testify on drug pricing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.